What Does Bollinger Band say about NovoCure Limited (NASDAQ:NVCR)?


Technical Indicators and Signals

The stochastic oscillator indicator is the important indicator to compare the security price over a certain period of time. The stochastic %K of NovoCure Limited (NASDAQ:NVCR) for the period of 9-Day stands at 28.29% while the stochastic %D for the same period stands at 16.48%.

The 7-Day Average Directional Index ADX (also known as Trend Strength Indicator) of NovoCure Limited (NASDAQ:NVCR) signals “Sell” while other important signals like the 20-Day Moving Average Vs. Price signals “Sell”.

Another important signal of trend and momentum of a security is 20-50 Day MACD Oscillator or Moving Average Convergence Divergence signals “Sell” for NovoCure Limited (NASDAQ:NVCR) while 20-100 Day MACD Oscillator indicates “Buy”.

Bollinger band is a volatility indicator of a certain security, currently NovoCure Limited (NASDAQ:NVCR)’s 20-Day Bollinger Band indicates “Hold”.

About Company

NovoCure Limited is an oncology company. The Company is engaged in developing a therapy called Tumor Treating Fields for the treatment of solid tumor cancers. It operates primarily in the United States, Germany, Switzerland and Japan. NovoCure Limited is based in Saint Helier, Channel Islands.

Previous Day Activity Analysis

On the last trading day, NovoCure Limited (NASDAQ:NVCR) opened the session at $17.65 and after going up 1.98% closed at $18. The stock gained 0.35 points in the last trade.

NovoCure Limited (NASDAQ:NVCR)’s stock fluctuated in the range of $17.42 and $18.20 during the previous active session. NovoCure Limited (NASDAQ:NVCR) traded with the volume of 883648 with average volume of 936.73 Million. The stock has MEDIUM volatility on the last trading session.

Currently the Beta for the company remains at 0 while ATR (Average True Range) and RSI (Relative Strength Index) are at 1.04 and 42.52 respectively.

Currently the Insider Ownership of the shares of NovoCure Limited (NASDAQ:NVCR) is at 1.4% and the shares outstanding are 97.19 Million.

Important Ratio Analysis

Some important ratios to consider here for NovoCure Limited (NASDAQ:NVCR) are discussed below:

Dividend yield of NovoCure Limited (NASDAQ:NVCR) stands at 0% whereas Price to Earnings P/E ratio stands at 0 while Forward P/E shows the value of 0.

The Price to Sale P/S and Price to Book P/B shows the value of 13.97 and 13.53 respectively. While Price to Cash P/C and Price to Free Cash Flow P/FCF stands at 9.49 and 0 correspondingly.

The Quick Ratio of NovoCure Limited (NASDAQ:NVCR) stands at 6 while the Current Ratio depicts the value of 6.7.

Return on Assets ROA of NovoCure Limited (NASDAQ:NVCR) is at -34.7% whereas, Return on Equity ROE and Return of Investment ROI of NovoCure Limited (NASDAQ:NVCR) stand at -69.5% and -52.7% respectively.

Stock Performance Analysis

The stock performance of NovoCure Limited (NASDAQ:NVCR) on the basis of 5 day trade show the dip of -1.64% whereas, the monthly performance of the stock shows decrease of -15.69%.

The quarterly performance of the stock remained in red zone with the value of -1.91% while six month performance of the shares of NovoCure Limited (NASDAQ:NVCR) remained bullish with the count of 62.16%.

The yearly and YTD performance of NovoCure Limited (NASDAQ:NVCR) remained up at 145.9% and 129.3% respectively.